Publications by authors named "Malgorzata McMasters"

Claim this Profile
A
A phase I clinical trial of lenalidomide combined with bortezomib for acute myeloid leukemia or myelodysplastic syndrome relapsing after allogeneic stem cell transplantation.
Brandon J Aubrey, Traci Blonquist, Malgorzata McMasters, Gabriela Hobbs, Steven McAfee

Leuk Res· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Asciminib plus dasatinib and prednisone for Philadelphia chromosome-positive acute leukemia.
Marlise R Luskin, Mark A Murakami, Julia Keating, Yael Flamand, Eric S Winer, Malgorzata McMasters

Blood· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase I First-in-Human Dose Escalation Study of the oral SF3B1 modulator H3B-8800 in myeloid neoplasms.
David P Steensma, Martin Wermke, Virginia M Klimek, Peter L Greenberg, Patricia Font, Malgorzata McMasters

Leukemia· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Casting a wider protective net: Anti-infective vaccine strategies for patients with hematologic malignancy and blood and marrow transplantation.
Malgorzata McMasters, Barbra M Blair, Hillard M Lazarus, Carolyn D Alonso

Blood Rev· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Parkinsonism reversed from treatment of pineal non-germinomatous germ cell tumor.
Sydni M Cole, Sasmit Sarangi, David Einstein, Malgorzata McMasters, Ron Alterman

Surg Neurol Int· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Alisertib plus induction chemotherapy in previously untreated patients with high-risk, acute myeloid leukaemia: a single-arm, phase 2 trial.
Andrew M Brunner, Traci M Blonquist, Daniel J DeAngelo, Malgorzata McMasters, Geoffrey Fell

Lancet Haematol· February 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The prevention and management of asparaginase-related venous thromboembolism in adults: Guidance from the SSC on Hemostasis and Malignancy of the ISTH.
Jeffrey I Zwicker, Tzu-Fei Wang, Daniel J DeAngelo, Mandy N Lauw, Jean M Connors, Malgorzata McMasters

J Thromb Haemost· February 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hypomethylating agent alters the immune microenvironment in acute myeloid leukaemia (AML) and enhances the immunogenicity of a dendritic cell/AML vaccine.
Myrna R Nahas, Dina Stroopinsky, Jacalyn Rosenblatt, Leandra Cole, Athalia R Pyzer, Malgorzata McMasters

Br J Haematol· May 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase 1 clinical trial evaluating abatacept in patients with steroid-refractory chronic graft-versus-host disease.
Myrna R Nahas, Robert J Soiffer, Haesook T Kim, Edwin P Alyea, Jon Arnason, Malgorzata McMasters

Blood· June 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Possible reactivation of chromosomally integrated human herpesvirus 6 after treatment with histone deacetylase inhibitor.
Ioannis Politikos, Malgorzata McMasters, Christine Bryke, David Avigan, Vassiliki A Boussiotis

Blood Adv· June 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bortezomib-based immunosuppression after reduced-intensity conditioning hematopoietic stem cell transplantation: randomized phase II results.
John Koreth, Haesook T Kim, Paulina B Lange, Samuel J Poryanda, Carol G Reynolds, Malgorzata McMasters

Haematologica· March 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase I study of lenalidomide plus chemotherapy with mitoxantrone, etoposide, and cytarabine for the reinduction of patients with acute myeloid leukemia.
Daniel J DeAngelo, Andrew M Brunner, Lillian Werner, David Avigan, Amir T Fathi, Malgorzata McMasters

Am J Hematol· February 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cabozantinib is well tolerated in acute myeloid leukemia and effectively inhibits the resistance-conferring FLT3/tyrosine kinase domain/F691 mutation.
Amir T Fathi, Traci M Blonquist, Daniela Hernandez, Philip C Amrein, Karen K Ballen, Malgorzata McMasters

Cancer· January 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A multicenter, retrospective, case-cohort study of the epidemiology and risk factors for Clostridium difficile infection among cord blood transplant recipients.
Carolyn D Alonso, David A Braun, Ishan Patel, Mona Akbari, Daniel Jungmyung Oh, Malgorzata McMasters

Transpl Infect Dis· August 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
MUC1-mediated induction of myeloid-derived suppressor cells in patients with acute myeloid leukemia.
Athalia Rachel Pyzer, Dina Stroopinsky, Hasan Rajabi, Abigail Washington, Ashujit Tagde, Malgorzata McMasters

Blood· March 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Individualized vaccination of AML patients in remission is associated with induction of antileukemia immunity and prolonged remissions.
Jacalyn Rosenblatt, Richard M Stone, Lynne Uhl, Donna Neuberg, Robin Joyce, Malgorzata McMasters

Sci Transl Med· December 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis